Skip to main content
Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system.
Published Web Locationhttps://doi.org/10.1016/j.contraception.2019.10.010
ObjectiveTo assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS).
Study designWe assessed pregnancy rates through 72 months in women aged 16-35 years at enrollment and safety in all participants (aged 16-45 years, n = 1751) in an ongoing 10-year phase-3 trial.
ResultsOver six years, nine pregnancies occurred (none in year 6) for a life-table pregnancy rate of 0.87 (95% CI 0.44-1.70). Adverse event rates remain low through 6 or more years of use. Two expulsions occurred in year 6.
ConclusionThis levonorgestrel 52 mg IUS is a highly effective and safe contraceptive over 6 years of use.
ImplicationsThe levonorgestrel 52 mg IUS shows high 6-year contraceptive efficacy and a low rate of adverse events through 6 or more years of use.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
Fast Web View:
Preparing document for printing…